Cellceutix (CTIX) . . . up 10% this morning. Bre
Post# of 98044
Cellceutix (CTIX) . . . up 10% this morning. Breakthrough cancer treatment starting Phase 1 clinical trials at world's foremost cancer research hospital, Dana Farber this week. Last chance to get in under a buck. Big potential!